drugset / Trial / NCT00818805

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

NCT00818805

Phase 4 Completed 50 enrolled Alcon Research
RandomizedCrossoverSingle-blindTreatment

Summary

To evaluate the efficacy of olopatadine 0.1% using the OHIO Chamber in patients with seasonal allergic conjunctivitis.

Timeline

Start
2008-07
Primary completion
2008-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Olopatadine Other / unclassified 0.1 % Topical
Subject Tranilast Small molecule 0.5 % Topical

Indications